ReviewFrontiers in immunology2025

Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer.

Yu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.